Literature DB >> 1700999

Molecular characterization and functional analysis of the leukocyte surface protein CD31.

H Stockinger1, S J Gadd, R Eher, O Majdic, W Schreiber, W Kasinrerk, B Strass, E Schnabl, W Knapp.   

Abstract

The CD31 Ag is a surface glycoprotein of 130 kDa with a broad cellular distribution. We show that among peripheral human blood cells, it is expressed on monocytes, granulocytes, platelets, and a subpopulation of lymphocytes. Activation of granulocytes leads to down-regulation of CD31 molecule expression. Sequence analysis and quantitative measurements of the relatedness of the CD31 molecule to other known proteins demonstrate that it consists of six Ig constant domains and that each domain bears substantial similarity to Fc gamma R domains. We find, however, that the CD31 molecule does not bind Ig Fc domains. On human monocytes we demonstrate that CD31 mAb recognizing certain epitopes of the CD31 molecule induce the generation of reactive oxygen metabolites. No such effect was seen with human granulocytes. By using two CD31 mAb, termed 1B5 and 7E4, we analyzed the requirements for activation of the monocyte respiratory burst via CD31 Ag in more detail. We show that signal transduction occurs via formation of a CD31 Ag-mAb-Fc gamma R complex involving either Fc gamma RI (CD64) or Fc gamma RII (CDw32) molecules.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700999

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  57 in total

1.  Phenotype of human T cells expressing CD31, a molecule of the immunoglobulin supergene family.

Authors:  H Stockinger; W Schreiber; O Majdic; W Holter; D Maurer; W Knapp
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

2.  The alleles of PECAM-1.

Authors:  Melanie S Novinska; Bradley C Pietz; Thomas M Ellis; Debra K Newman; Peter J Newman
Journal:  Gene       Date:  2006-04-11       Impact factor: 3.688

3.  Temporo-spatial distribution of blood vessels in human lumbar intervertebral discs.

Authors:  Andreas G Nerlich; Rainer Schaaf; Beat Wälchli; Norbert Boos
Journal:  Eur Spine J       Date:  2006-09-01       Impact factor: 3.134

4.  Analysis of function-associated receptor molecules on peripheral blood and synovial fluid granulocytes from patients with rheumatoid and reactive arthritis.

Authors:  T Felzmann; S Gadd; O Majdic; D Maurer; P Petera; J Smolen; W Knapp
Journal:  J Clin Immunol       Date:  1991-07       Impact factor: 8.317

Review 5.  PECAM-1: regulator of endothelial junctional integrity.

Authors:  Jamie R Privratsky; Peter J Newman
Journal:  Cell Tissue Res       Date:  2014-01-17       Impact factor: 5.249

6.  Lactosylceramide recruits PKCalpha/epsilon and phospholipase A2 to stimulate PECAM-1 expression in human monocytes and adhesion to endothelial cells.

Authors:  NanLing Gong; Heming Wei; Sanaul Haq Chowdhury; Subroto Chatterjee
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-14       Impact factor: 11.205

7.  Signal transduction via Fc gamma R and Mac-1 alpha-chain in monocytes and polymorphonuclear leucocytes.

Authors:  S J Gadd; R Eher; O Majdic; W Knapp
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

8.  Optimisation and validation of immunohistochemistry protocols for cancer research.

Authors:  Peter Ella-Tongwiis; Alexander Makanga; Iqbal Shergill; Stephen Fôn Hughes
Journal:  Histol Histopathol       Date:  2021-02-22       Impact factor: 2.303

9.  EphrinB2 reverse signaling protects against capillary rarefaction and fibrosis after kidney injury.

Authors:  Yujiro Kida; Nicholas Ieronimakis; Claudia Schrimpf; Morayma Reyes; Jeremy S Duffield
Journal:  J Am Soc Nephrol       Date:  2013-03-14       Impact factor: 10.121

10.  Studies of lymphocyte transendothelial migration: analysis of migrated cell phenotypes with regard to CD31 (PECAM-1), CD45RA and CD45RO.

Authors:  I N Bird; J H Spragg; A Ager; N Matthews
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.